Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure

Circulation. 1998 Jun 16;97(23):2316-22. doi: 10.1161/01.cir.97.23.2316.

Abstract

Background: The failing myocardium is characterized by decreased force production, slowed relaxation, and depressed responses to beta-adrenergic stimulation. In some heart failure patients, heart function is so poor that a left ventricular assist device (LVAD) is inserted as a bridge to transplantation. In the present research, we investigated whether circulatory support with an LVAD influenced the functional properties of myocytes from the failing heart.

Methods and results: Myocytes were isolated from human explanted failing hearts (HF-myocytes) and failing hearts with antecedent LVAD support (HF-LVAD-myocytes). Studies of myocyte function indicated that the magnitude of contraction was greater (9.6+/-0.7% versus 6.9+/-0.5% shortening), the time to peak contraction was significantly abbreviated (0.37+/-0.01 versus 0.75+/-0.04 seconds), and the time to 50% relaxation was reduced (0.55+/-0.02 versus 1.45+/-0.11 seconds) in the HF-LVAD-myocytes compared with the HF-myocytes (P<0.05). The HF-LVAD-myocytes had larger contractions than the HF-myocytes at all frequencies of stimulation tested. The negative force-frequency relationship of the HF-myocytes was improved in HF-LVAD-myocytes but was not reversed. Responses to beta-adrenergic stimulation (by isoproterenol) were greater in HF-LVAD-myocytes versus HF-myocytes.

Conclusions: The results of the study strongly support the idea that circulatory support with an LVAD improves myocyte contractile properties and increases beta-adrenergic responsiveness.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenergic beta-Agonists / pharmacology
  • Adult
  • Aged
  • Cells, Cultured
  • Coronary Circulation
  • Electric Stimulation
  • Electrophysiology
  • Female
  • Fluorescent Dyes
  • Heart Failure / therapy*
  • Heart-Assist Devices*
  • Humans
  • Indoles
  • Isoproterenol / pharmacology
  • Male
  • Middle Aged
  • Muscle Fibers, Skeletal / drug effects
  • Muscle Fibers, Skeletal / physiology*
  • Myocardial Contraction / physiology
  • Myocardium / cytology*
  • Ventricular Dysfunction, Left / therapy

Substances

  • Adrenergic beta-Agonists
  • Fluorescent Dyes
  • Indoles
  • Isoproterenol
  • indo-1